Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed, indicating a metadata version update that does not alter study details or displayed information.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and Revision: v3.4.1 were removed. These updates are administrative and do not affect the study details on the page.SummaryDifference0.3%

- Check45 days agoChange DetectedA site-wide notice about a lapse in government funding was added, and the page shows Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check52 days agoChange DetectedAdministrative metadata updates were applied: additions include Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; deletions remove Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.